It is widely accepted that beta-amyloid oligomers (A beta os) play a key role in the progression of Alzheimer's disease (AD) by inducing neuron damage and cognitive impairment, but A beta os are highly heterogeneous in their size, structure and cytotoxicity, making the corresponding studies tough to carry out. Nevertheless, a number of studies have recently made remarkable progress in the describing the characteristics and pathogenicity of A beta os. We here review the mechanisms by which A beta os exert their neuropathogenesis for AD progression, including receptor binding, cell membrane destruction, mitochondrial damage, Ca(2+)homeostasis dysregulation and tau pathological induction. We also summarize the characteristics and pathogenicity...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
It is estimated that Alzheimer’s disease (AD) affects tens of millions of people, comprising n...
Recent studies point to a critical role of soluble β-amyloid oligomers in the pathogenesis of one of...
It is estimated that Alzheimer’s disease (AD) affects tens of millions of people, comprising n...
It is generally believed that the amyloid-β peptide plays a central causative role in the pathogenes...
Amyloid beta (Aβ) is a peptide of 39–43 amino acids found in large amounts and forming deposits in t...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
Amyloid beta-protein (Abeta) assemblies are thought to play primary roles in Alzheimer disease (AD)....
There is an increasing amount of evidence showing the importance of intermediate aggregation species...
Oligomers of amyloid-beta (A beta) have emerged as the primary toxic agents responsible for early sy...
Amyloid beta (Aβ) peptide is the major constituent of the extracellular amyloid plaques deposited in...
International audienceAmyloid-beta (A beta) oligomers are the suspected culprit as initiators of Alz...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
It is estimated that Alzheimer’s disease (AD) affects tens of millions of people, comprising n...
Recent studies point to a critical role of soluble β-amyloid oligomers in the pathogenesis of one of...
It is estimated that Alzheimer’s disease (AD) affects tens of millions of people, comprising n...
It is generally believed that the amyloid-β peptide plays a central causative role in the pathogenes...
Amyloid beta (Aβ) is a peptide of 39–43 amino acids found in large amounts and forming deposits in t...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
Amyloid beta-protein (Abeta) assemblies are thought to play primary roles in Alzheimer disease (AD)....
There is an increasing amount of evidence showing the importance of intermediate aggregation species...
Oligomers of amyloid-beta (A beta) have emerged as the primary toxic agents responsible for early sy...
Amyloid beta (Aβ) peptide is the major constituent of the extracellular amyloid plaques deposited in...
International audienceAmyloid-beta (A beta) oligomers are the suspected culprit as initiators of Alz...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...
The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial. Neu...